Since gamma-aminobutyric acid does not form a stable zwitterionic species in the gas phase, as calculated at the HF/6-311++G** level, the GABA.2H(2)O system was optimized for several neutral and zwitterionic GABA tantomers/conformers. The obtained molecular geometries and vibrational frequencies determined for the dihydrates reflect structural changes for GABA due to close and strongly bound water molecules. By use of GABA geometries optimized in the dihydrates, relative free energies of different species in aqueous solution were calculated. MP2/6-311++G**//HF/6-311++G"* energy values show that the neutral form is strongly preferred over the zwitterionic one for the isolated GABA species. The neutral tautomer, which is most stable in the gas phase, is only marginally changed by hydration; it is without an intramolecular hydrogen bond and has nearly gauche-gauche arrangements, 54 and -83 degrees, for the NCCC and the CCCC torsion angles, respectively, as determined in the dihydrate; In aqueous solution the zwitterionic structure is dominant. Comparison of cyclic gauche-gauche forms and a partially extended, gauche-trans structure indicates the preference of the more extended form. This structure differs from the trans-gauche zwitterionic conformer found for GABA by X-ray experiments in the crystalline phase. The experimental GABA conformer is not stable either in the isolated form or in the gas-phase dihydrate. It is, however, more stable by about 6.5 kcal/mol than the gas-phase gauche-trans form, as turned out in a restricted geometry optimization. Such a large internal stabilization may allow the existence (even preference) of the experimental zwitterionic GABA structure in aqueous solution if solvent effects are preferable. Partition of GABA between water and chloroform is not favored. At least 7.5 kcal/mol free energy increase is required if the zwitterion either directly or after transformation to a neutral form would leave the aqueous phase and enter chloroform. This result. supports the experimental finding that GABA does not cross the blood-brain barrier.